Convulsive status epilepticus (adult UK pathway)
A source-linked educational visual of adult convulsive status epilepticus first-line, second-line and refractory treatment from NICE NG217.
Important safety note
This visual algorithm is an educational representation of published UK clinical guidance and is not a substitute for clinical judgement, local protocols, senior/specialist advice, or the original guideline. Verify current guidance before clinical use.
Scope and source
- Scope
- Adults with convulsive status epilepticus in UK emergency and acute-care services.
- Jurisdiction
- UK
- Primary guidance
- NICE NG217: Epilepsies in children, young people and adults
- Guidance last updated
- 2025-01-30
- Clinical reference reviewed
- 2026-09-08
- Review due
- 2027-03-08
Interactive clinical algorithm
This source-backed visual algorithm is available in the interactive page experience. Open the original guidance and the node notes before clinical use.
How to read this visual
- Read across the columns for the phases of the pathway; the swimlanes are who acts — Emergency team, Timing and monitoring, Expert and critical care.
- Bold marks the dose, threshold or time limit that decides the next step; the rest of a label is context.
- Time the seizure from onset and treat reversible causes in parallel.
- Follow the escalation branch after each defined treatment response point.
Clinical notes
- Use local adult status-epilepticus dosing guidance and seek senior/anaesthetic help early.
- This pathway is for convulsive status; ongoing altered consciousness after convulsions may need EEG and specialist assessment.
Sources
- NICE NG217: Treating status epilepticus (NICE; 2025-01-30)
Open an editable reference copy
Create a personal educational copy. Verify the original guidance before clinical use.